T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
AES
AES
$10.5B
| $1.19B | 0.24% |
89,449,649
+3,037,758
| +4% | +$40.8M |
|
102
Celanese
CE
$4.92B
| $1.18B | 0.24% |
16,451,134
-1,108,755
| -6% | -$73.8M |
|
|
IHS
103
DELISTED
IHS INC CL-A COM STK
IHS
| $1.18B | 0.24% |
9,171,501
+2,729,117
| +42% | +$341M |
|
104
PNC Financial Services
PNC
$101B
| $1.17B | 0.24% |
12,212,505
-154,798
| -1% | -$14.6M |
|
105
Carnival Corporation Ltd
CCL
$38B
| $1.17B | 0.24% |
23,589,390
-3,172,363
| -12% | -$150M |
|
106
Northern Trust
NTRS
$34.4B
| $1.16B | 0.24% |
15,217,971
+498,048
| +3% | +$37.1M |
|
|
107
Occidental Petroleum
OXY
$59B
| $1.16B | 0.24% |
14,912,191
+9,773,576
| +190% | +$763M |
|
108
Crown Castle
CCI
$31.3B
| $1.12B | 0.23% |
13,950,851
-3,953,606
| -22% | -$330M |
|
109
MGM Resorts International
MGM
$11.1B
| $1.11B | 0.23% |
60,666,722
-6,916,883
| -10% | -$140M |
|
110
Verizon
VZ
$196B
| $1.1B | 0.23% |
23,688,849
-611,827
| -3% | -$29.9M |
|
111
Exelon
EXC
$46.2B
| $1.1B | 0.23% |
49,015,591
+3,116,688
| +7% | +$74.7M |
|
112
BioMarin Pharmaceuticals
BMRN
$13.5B
| $1.09B | 0.23% |
7,997,463
-177,126
| -2% | -$21.9M |
|
113
HCA Healthcare
HCA
$89.1B
| $1.08B | 0.22% |
11,913,256
+995,014
| +9% | +$79.7M |
|
114
Nike
NKE
$61.3B
| $1.08B | 0.22% |
19,994,924
-208,022
| -1% | -$10.7M |
|
|
TYC
115
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $1.08B | 0.22% |
26,690,447
-3,081,520
| -10% | -$131M |
|
116
Flowserve
FLS
$10.3B
| $1.07B | 0.22% |
20,323,600
-829,293
| -4% | -$46.2M |
|
117
Alkermes
ALKS
$8.26B
| $1.03B | 0.21% |
16,065,948
-94,180
| -0.6% | -$5.76M |
|
118
Hilton Worldwide
HLT
$70.8B
| $1.03B | 0.21% |
12,502,493
+1,380,986
| +12% | +$121M |
|
|
HSP
119
DELISTED
HOSPIRA INC
HSP
| $988M | 0.2% |
11,140,867
-8,366,250
| -43% | -$737M |
|
120
United Airlines
UAL
$41B
| $986M | 0.2% |
18,604,085
-4,902,366
| -21% | -$284M |
|
121
Norwegian Cruise Line
NCLH
$8.59B
| $986M | 0.2% |
17,594,721
+1,099,317
| +7% | +$59.1M |
|
|
CXO
122
DELISTED
CONCHO RESOURCES INC.
CXO
| $985M | 0.2% |
8,652,180
+1,563,539
| +22% | +$190M |
|
|
PLL
123
DELISTED
PALL CORP
PLL
| $983M | 0.2% |
7,902,235
-1,276,305
| -14% | -$144M |
|
124
Ametek
AME
$58.8B
| $982M | 0.2% |
17,918,044
+453,845
| +3% | +$24.3M |
|
125
Las Vegas Sands
LVS
$29.6B
| $975M | 0.2% |
18,548,664
+5,245,184
| +39% | +$280M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.